Eurofins Scientific SE




Healthcare Facilities & Services

Market Closed - Euronext Paris 16:35:25 17/05/2024 BST 5-day change 1st Jan Change
58.26 EUR -1.65% Intraday chart for Eurofins Scientific SE +1.04% -1.22%
LockThis Alphavalue article, the European leader in independent research, is only available to subscribers .
Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!
Already a customer? Log In
Eurofins Scientific to Expand US Battery Materials Testing Capabilities MT
Eurofins Scientific expands capacity in the USA CF
Corella Resources Confirms High Purity Alumina Production MT
CAC40: France's rating maintained = non-event CF
CAC40: starts the week slightly up, crosses the 8100 mark CF
CAC40: interest rates soar, pulling back below 8100 pts CF
EUROFINS SCIENTIFIC : Q1 sees a lacklustre start to the year; 2024 outlook confirmed Alphavalue
CAC40: reverses course under pressure from rates at their zenith CF
CAC40: rise to 8.150, but interest-rate tensions hinder progress CF
Transcript : Eurofins Scientific SE, Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024
CAC40: close to equilibrium despite Kering's plunge CF
Eurofins: organic growth close to 7% in Q1 CF
Eurofins Scientific SE's Equity Buyback announced on October 3, 2022, has expired. CI
CAC40: up sharply, back over 8100 pts CF
CAC40: week ends at half-mast, gold at its zenith CF
CAC40: pullback reduced, WStreet +0.7%, Brent at $91, Gold at $233 CF
CAC40: easily preserves 8,000Pts, NFP has no impact CF
CAC40: ends the day balanced after a salvo of statistics CF
CAC40: frozen at 8,155, W-Street well disposed, gold at its zenith CF
CAC40: indecisive towards 8,160, W-Street climbs back to the top CF
EUROFINS SCIENTIFIC : Berenberg raises its price target CF
CAC40: up slightly after PMI figures CF
Eurofins Scientific to Purchase US-based Ascend Clinical MT
Eurofins completes acquisition of Ascend Clinical CF
Eurofins Scientific SE acquired Ascend Clinical, LLC. CI
Chart Eurofins Scientific SE
More charts
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Mean consensus
Number of Analysts
Last Close Price
58.26 EUR
Average target price
60.88 EUR
Spread / Average Target

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ERF Stock
  4. News Eurofins Scientific SE
  5. Eurofins Scientific: Q1 sees a lacklustre start to the year; 2024 outlook confirmed